HERVOLUTION Therapeutics Appoints Biotech Builder J. Robert Coleman as CEO to Accelerate Groundbreaking Immunotherapies to Treat Dark Genome Targets in Cancer, Aging, and Neurodegeneration

HERVOLUTION Therapeutics United States of America United Kingdom Denmark

View original content:https://www.prnewswire.co.uk/news-releases/hervolution-therapeutics-appoints-biotech-builder-j-robert-coleman-as-ceo-to-accelerate-groundbreaking-immunotherapies-to-treat-dark-genome-targets-in-cancer-aging-and-neurodegeneration-302019006.html

@ prnewswire.co.uk | CH0038389992 HERVOLUTION